From: Can the vector space model be used to identify biological entity activities?
Subnetwork | Dimensional Space | New Interactions in 2004 | Confirmations Issued in 2005 | Distribution at the Top 100 New Interactions | ||
---|---|---|---|---|---|---|
AVG | MAX | SUM | ||||
1 | disease × drug | 275 | 5 | 3 | 4 | 4 |
2 | disease × gene | 167 | 2 | 2 | 2 | 2 |
3 | disease × target | 348 | 2 | 1 | 1 | 1 |
4 | drug × gene | 119 | 0 | 0 | 0 | 0 |
5 | drug × target | 282 | 4 | 3 | 3 | 3 |
6 | gene × target | 152 | 3 | 2 | 2 | 3 |
7 | disease × drug × gene | 308 | 4 | 1 | 1 | 4 |
8 | disease × drug × target | 786 | 9 | 2 | 2 | 3 |
9 | disease × gene × target | 242 | 2 | 2 | 2 | 2 |
10 | drug × gene × target | 76 | 0 | 0 | 0 | 0 |
11 | disease × drug × gene × target | 175 | 1 | 1 | 1 | 0 |
Total | 2 930 | 32 | 17 | 18 | 22 | |
% | 53 | 56 | 69 |